Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.

about

Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.

Item

http://www.wikidata.org/entity/Q55266544

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical significance of andro ...... an immunohistochemistry study.

@en

Clinical significance of andro ...... an immunohistochemistry study.

@nl

type

Item

label

Clinical significance of andro ...... an immunohistochemistry study.

@en

Clinical significance of andro ...... an immunohistochemistry study.

@nl

prefLabel

Clinical significance of andro ...... an immunohistochemistry study.

@en

Clinical significance of andro ...... an immunohistochemistry study.

@nl

P1476

Clinical significance of andro ...... an immunohistochemistry study.

@en

P2093

Ke-Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Li-Li Tang

http://www.w3.org/2001/XMLSchema#string

Ya-Xuan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer

Comprehensive molecular portraits of human breast tumours

Current medical treatment of estrogen receptor-positive breast cancer

Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis

The omics of triple-negative breast cancers

Global cancer statistics, 2012

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.

P304

10008-10016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8548

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29844843

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

5958876

http://www.w3.org/2001/XMLSchema#string